Breaking News

India Responds to IP Issues Raised Over Novartis Case
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

On his visit to the World Intellectual Property Organization in Geneva, India’s Trade Minister Anand Sharma gave some straightforward answers and raised some cogent issues. The tirade over intellectual property rights raised by pharmaceutical companies after the top court in India denied Novartis’ bid for patent protection on its cancer drug, Glivec, was addressed by Sharma.

The first thing Sharma said was that India’s government had never exercised its executive power to compel any company to make cheap drugs available. However, India reserved its right to do so, if and whenever the government feels such a step is required.

While admitting that protection of intellectual property rights was a critical question, Sharma observed, “What is good, to allow people to die or to make the medicine available? That’s the larger question.”

  
What
Where


Sharma said that Novartis had “absolutely no reason to complain” against the India government because the case was decided by the independent judiciary and not by the executive wing of the government.

Sharma further stressed that India was a source of a huge amount of intellectual property and had an interest in protecting such property, and as such was respectful of the same when it came to others. He said the Glivec decision would not affect investment into India.

However, Sharma stressed that the court decision to deny Novartis patent protection for Glivec was absolutely justified under the intellectual property rules of the World Trade Organization. He said, the rules, also known as the TRIPS agreement contains “a flexibility that has been negotiated and integral” to TRIPS, and developed countries often use the right to compulsory licensing.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




In fact, Sharma drew attention to the fact that developed countries had used the right to compulsory licensing at least 160 times, within which more than 63 times, the power was used by the executive. So, when it came to developing countries, they had the right to make available affordable medicines in response to life-threatening diseases or epidemics.





 

RELEVANT JOBS

Staff Attorney

USA-VA-Fairfax

The Staff Attorney is responsible for managing the Fund’s delinquent contribution and withdraw...

Apply now

Associate Attorney

USA-TX-Sugar Land

Civil Litigation Firm in Sugar Land, TX. is seeking an attorney with 2 - 5 years litigation exp...

Apply now

Associate Attorney

USA-CA-Sacramento

Schuering Zimmerman & Doyle, LLP (SZD) is seeking a motivated associate with two plus years of civil...

Apply now

Business / Commercial Litigation Associate

USA-GA-Atlanta

Are you motivated to think through a problem? Do you enjoy the challenge of learning something ...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Personal Injury Litigator

USA-VA-Fairfax

Northern Virginia office of our client is seeking a personal injury litigator with 4+ years of stron...

Apply Now

Associate Attorney

USA-CA-Larkspur

Larkspur office of our client seeks an associate attorney with 4-6 years of experience/background pr...

Apply Now

Associate Attorney

USA-MI-Bloomfield Hills

Bloomfield Hills office of a BCG Attorney Search Top Ranked Law Firm seeks an associate attorney wit...

Apply Now

Most Popular

SEARCH IN ARCHIVE

To Top